Our Figure 5 showed a reduction of AXL and survivin, two known aggressiveness-regulating molecules of prostate cancer [26,27,28,42], by combinatorial lovastatin and AC extract, which echoed the roles of RB in cancer control. Here, AXL is linked to prostate carcinoma.